COVID-19 infection among patients with autoinflammatory diseases: a study on 117 French patients compared with 1545 from the French RMD COVID-19 cohort: COVIMAI - the French cohort study of SARS-CoV-2 infection in patient with systemic autoinflammatory diseases.

Rim BourguibaMaeva KyhengIsabelle Kone-PautDiane RouzaudJerome AvouacMathilde DevauxNassim Ait AbdallahBruno FautrelNicole Ferreira-MaldentVincent LangloisEmmanuel LedoultHubert NiellyViviane QueyrelJérémie SellamNathalie TieuliePascal ChazerainPhilippe EvonJulien LabreucheLéa SaveyVeronique HentgenGilles GrateauStéphanie Ducharme-Bénardnull null

Published in: RMD open (2022)

As identified in the whole French RMD COVID-19 cohort, patients with SAID on corticosteroids and with multiple comorbidities are prone to develop more severe COVID-19 forms.

Keyphrases

coronavirus disease
sars cov
respiratory syndrome coronavirus
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis